| NDC Code | 51662-1549-3 |
|---|
| Package Description | 25 POUCH in 1 CASE (51662-1549-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1549-2) / 2 mL in 1 VIAL, SINGLE-DOSE (51662-1549-1) |
|---|
| Product NDC | 51662-1549 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Verapamil Hydrochloride |
|---|
| Non-Proprietary Name | Verapamil Hydrochloride |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20220520 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA212965 |
|---|
| Manufacturer | HF Acquisition Co LLC, DBA HealthFirst |
|---|
| Substance Name | VERAPAMIL HYDROCHLORIDE |
|---|
| Strength | 2.5 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
|---|